These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 2825856)
1. [Global approach to the treatment of small cell bronchial cancers]. Lebeau B Bull Cancer; 1987; 74(5):555-8. PubMed ID: 2825856 [TBL] [Abstract][Full Text] [Related]
2. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy]. Payne DG; Murray N; Warde P Bull Cancer; 1994 Feb; 81(2):119-28. PubMed ID: 7894117 [TBL] [Abstract][Full Text] [Related]
3. [Polychemotherapy using methotrexate, adriamycin, cyclophosphamide and CCNU (MACC) in patients with advanced adenocarcinoma and large cell carcinoma of the lung]. Karnicka-Młodkowska H; Jassem J; Mierzewski P; Słupek A; Mierzwa W; Decker E; Prokop A; Krawczyk K; Kowal E; Firlik M Pneumonol Pol; 1986 Dec; 54(12):546-51. PubMed ID: 3035511 [No Abstract] [Full Text] [Related]
4. Adriamycin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer. Ardizzoni A; Canobbio L; Pronzato P; Repetto L; Serrano J; Benvenuto F; Simonassi C; Baracco F; Faravelli B; Nosenzo M Chemioterapia; 1986 Dec; 5(6):416-9. PubMed ID: 3026668 [TBL] [Abstract][Full Text] [Related]
5. Cyclic alternating chemotherapy for small cell carcinoma of the lung. Murray N; Shah A; Wilson K; Goldie J; Voss N; Fryer C; Klimo P; Coy P; Hadzic E; Gudauskas G Cancer Treat Rep; 1985 Nov; 69(11):1241-2. PubMed ID: 3004724 [TBL] [Abstract][Full Text] [Related]
6. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group. Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach. Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M; J BUON; 2006; 11(1):31-7. PubMed ID: 17318949 [TBL] [Abstract][Full Text] [Related]
8. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial]. Salvati F; Pallotta G; Antilli A; Nunziati F; De Marinis F; Lucchesi M G Ital Chemioter; 1984; 31(1-2):185-9. PubMed ID: 6088341 [No Abstract] [Full Text] [Related]
9. [Etoposide in the treatment of small-cell lung cancer]. Ueoka H Gan To Kagaku Ryoho; 1996 Dec; 23(14):1920-4. PubMed ID: 8978798 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of 2 regimens of chemotherapy of small cell carcinoma of the lung: modified Hansen method and the ACOM method]. Jassem J; Karnicka-Młodkowska H; Mierzewski P; Decker E; Krawczyk K; Lisowska B; Malak K; Słupek A; Sokół A; Sosnowski K Pneumonol Pol; 1988 Apr; 56(4):142-51. PubMed ID: 2842737 [No Abstract] [Full Text] [Related]
11. Survival analysis of patients with small cell lung cancer. Serdengeçti S; Büyükünal E; Molinas N; Demirelli FH; Berkarda N; Eyüboğlu H; Derman U; Berkarda B Chemioterapia; 1988 Apr; 7(2):117-21. PubMed ID: 2840214 [TBL] [Abstract][Full Text] [Related]
12. [Therapeutic results in the treatment of small cell bronchial cancer: experience of the EORTC Lung Cancer Working Party (Belgium)]. Sculier JP Bull Cancer; 1987; 74(5):565-8. PubMed ID: 2825858 [TBL] [Abstract][Full Text] [Related]
13. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen). Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S; Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326 [TBL] [Abstract][Full Text] [Related]
14. [Pilot study of sequential chemotherapy and radiation therapy using of liniac and fast neutron for limited small cell lung cancer]. Takiguchi Y; Nagao K; Miyamoto T; Takamura M; Yasukawa T; Kuriyama T Gan To Kagaku Ryoho; 1995 Jun; 22(7):957-9. PubMed ID: 7794004 [No Abstract] [Full Text] [Related]
15. Randomized trial comparing chemotherapy alone and chemotherapy plus chest irradiation in limited stage small cell lung cancer: a preliminary report. Ohnoshi T; Hiraki S; Kawahara S; Yamashita H; Yonei T; Ishii J; Egawa T; Kozuka A; Hiraki Y; Kimura I Jpn J Clin Oncol; 1986 Sep; 16(3):271-7. PubMed ID: 3022036 [TBL] [Abstract][Full Text] [Related]
16. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy. Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527 [TBL] [Abstract][Full Text] [Related]
17. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK; J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033 [TBL] [Abstract][Full Text] [Related]